Making the case for the MDT in NSCLC

touchMDT for touchONCOLOGY Listen to a medical oncologist, a pathologist, a radiation oncologist and an oncology nurse practitioner discuss how to optimize treatment decisions, taking into account emerging therapies as well as patient expectations and preferences. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA  Pathologist: Prof. Keith Kerr, UK Radiation oncologist: Prof. Andrea Bezjak, Canada Oncology nurse practitioner: Dr Marianne Davies, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics,  Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/mdt-navigating-diagnosis-and-treatment-nsclc/